U.S. markets open in 7 hours 51 minutes
  • S&P Futures

    4,390.75
    -3.00 (-0.07%)
     
  • Dow Futures

    34,860.00
    +26.00 (+0.07%)
     
  • Nasdaq Futures

    14,982.50
    -29.00 (-0.19%)
     
  • Russell 2000 Futures

    2,224.90
    +4.20 (+0.19%)
     
  • Crude Oil

    72.78
    +0.39 (+0.54%)
     
  • Gold

    1,815.70
    +16.00 (+0.89%)
     
  • Silver

    25.32
    +0.44 (+1.76%)
     
  • EUR/USD

    1.1861
    +0.0014 (+0.12%)
     
  • 10-Yr Bond

    1.2610
    0.0000 (0.00%)
     
  • Vix

    18.31
    -1.05 (-5.42%)
     
  • GBP/USD

    1.3936
    +0.0028 (+0.20%)
     
  • USD/JPY

    109.6920
    -0.2180 (-0.20%)
     
  • BTC-USD

    39,948.37
    +10.10 (+0.03%)
     
  • CMC Crypto 200

    934.84
    +4.91 (+0.53%)
     
  • FTSE 100

    7,016.63
    +20.55 (+0.29%)
     
  • Nikkei 225

    27,761.93
    +180.27 (+0.65%)
     

Avid Bioservices (CDMO) Stock Jumps 7.2%: Will It Continue to Soar?

·1 min read

Avid Bioservices CDMO shares rallied 7.2% in the last trading session to close at $23.38. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 9.8% gain over the past four weeks.

Increasing revenues on the back of new business deals is driving the company's prospect, leading to higher share prices.

Price and Consensus

Price Consensus Chart for CDMO
Price Consensus Chart for CDMO

This contract manufacturer is expected to post break-even quarterly earnings per share in its upcoming report, which represents a year-over-year change of +100%. Revenues are expected to be $20.7 million, up 64.9% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

For Avid Bioservices, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CDMO going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank 3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Avid Bioservices, Inc. (CDMO) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research